E.g., 03/27/2019
E.g., 03/27/2019

bioMérieux enlarges its pathogen identification capability on VITEK® MS

06 July, 2016

With a database of more than 15,000 strains VITEK® MS improves clinical decision-making for infectious diseases

bioMerieux Receives FDA Clearance for Expanded Use of VIDAS® B•R•A•H•M•S PCT Test for Managing Sepsis Patients with Elevated Risk of Mortality

01 July, 2016

Tracking PCT – a biomarker for bacterial infections – over time provides strong indication of likely mortality, enabling physicians to personalize care for high-risk patients

New website dedicated antimicrobial resistance

20 June, 2016

bioMérieux has launched a new website dedicated antimicrobial resistance.

bioMérieux acquires Hyglos

01 June, 2016

bioMérieux acquires Hyglos and expands its offering to the detection of endotoxins in pharmaceutical products

bioMérieux and the Lyon Civil Hospitals strengthen their collaboration

31 May, 2016

bioMérieux and the Lyon Civil Hospitals strengthen their collaboration and expand their partnership to include Claude Bernard University Lyon 1   Two joint research laboratories focused on a common goal: advancing medical research for the benefit of patients  

bioMérieux – First-Quarter 2016 Business Review

26 April, 2016

bioMérieux, a world leader in the field of in vitro diagnostics, today released its business review for the three months ended March 31, 2016. 

Pioneering Diagnostics